• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麸质无谷蛋白饮食前后乳糜泻患者体内抗酿酒酵母抗体和抗中性粒细胞胞浆周缘抗体情况

Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.

作者信息

Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi F B, Volta U

机构信息

Department of Internal Medicine, Alma Mater Studiorum, University of Bologna, Policlinico Sant'Orsola-Malpighi, 40138 Bologna, Italy.

出版信息

Aliment Pharmacol Ther. 2005 Apr 1;21(7):881-7. doi: 10.1111/j.1365-2036.2005.02417.x.

DOI:10.1111/j.1365-2036.2005.02417.x
PMID:15801923
Abstract

BACKGROUND

Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic autoantibodies are markers of Crohn's disease and ulcerative colitis respectively.

AIM

To determine the prevalence of anti-S. cerevisiae and perinuclear anti-neutrophil cytoplasmic autoantibodies in a large series of coeliac disease patients before and after gluten free diet, and to correlate anti-S. cerevisiae-positivity with intestinal mucosal damage.

METHODS

One hundred and five consecutive coeliac disease patients and 141 controls (22 ulcerative colitis, 24 Crohn's disease, 30 primary sclerosing cholangitis, 15 postenteritis syndrome, 50 blood donors) were tested for anti-S. cerevisiae by enzyme-linked immunosorbent assay and for perinuclear anti-neutrophil cytoplasmic autoantibodies by indirect immunofluorescence.

RESULTS

In coeliac disease anti-S. cerevisiae (immunoglobulin G and/or immunoglobulin A) were slightly less frequent (59%) than in Crohn's disease (75%, P = 0.16) and significantly more frequent than in ulcerative colitis (27%), primary sclerosing cholangitis (30%), postenteritis syndrome (26%) and blood donors (4%) (P = 0.009, P = 0.0002, P = 0.025, P < 0.0001). No correlation was found between anti-S. cerevisiae and degree of mucosal damage. Perinuclear anti-neutrophil cytoplasmic autoantibodies were detected only in one coeliac. After gluten free diet the disappearance of anti-S. cerevisiae-immunoglobulin A (93%) was more frequent than that of immunoglobulin G (17%, P = 0.0001); perinuclear anti-neutrophil cytoplasmic autoantibodies disappeared in the only coeliac positive at diagnosis.

CONCLUSION

More than half of untreated coeliacs are anti-S. cerevisiae-positive irrespective of the severity of mucosal damage. Differently from immunoglobulin A, anti-S. cerevisiae-immunoglobulin G persisted in more than 80% after gluten free diet. The high prevalence of anti-S. cerevisiae in coeliac disease suggests that they may be the effect of a non-specific immune response in course of chronic small bowel disease.

摘要

背景

抗酿酒酵母抗体和核周型抗中性粒细胞胞浆自身抗体分别是克罗恩病和溃疡性结肠炎的标志物。

目的

确定大量乳糜泻患者在无麸质饮食前后抗酿酒酵母抗体和核周型抗中性粒细胞胞浆自身抗体的患病率,并将抗酿酒酵母抗体阳性与肠道黏膜损伤相关联。

方法

对105例连续的乳糜泻患者和141名对照者(22例溃疡性结肠炎、24例克罗恩病、30例原发性硬化性胆管炎、15例肠炎后综合征、50名献血者)进行抗酿酒酵母抗体的酶联免疫吸附测定及核周型抗中性粒细胞胞浆自身抗体的间接免疫荧光检测。

结果

在乳糜泻患者中,抗酿酒酵母抗体(免疫球蛋白G和/或免疫球蛋白A)的出现频率略低于克罗恩病患者(59%比75%,P = 0.16),但显著高于溃疡性结肠炎患者(27%)、原发性硬化性胆管炎患者(30%)、肠炎后综合征患者(26%)及献血者(4%)(P = 0.009、P = 0.0002、P = 0.025、P < 0.0001)。未发现抗酿酒酵母抗体与黏膜损伤程度之间存在相关性。仅在1例乳糜泻患者中检测到核周型抗中性粒细胞胞浆自身抗体。无麸质饮食后,抗酿酒酵母免疫球蛋白A消失(93%)的频率高于免疫球蛋白G(17%,P = 0.0001);核周型抗中性粒细胞胞浆自身抗体在诊断时唯一阳性的乳糜泻患者中消失。

结论

超过半数未经治疗的乳糜泻患者抗酿酒酵母抗体呈阳性,与黏膜损伤严重程度无关。与免疫球蛋白A不同,无麸质饮食后超过80%的抗酿酒酵母免疫球蛋白G持续存在。乳糜泻患者中抗酿酒酵母抗体的高患病率表明,它们可能是慢性小肠疾病过程中非特异性免疫反应的结果。

相似文献

1
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.麸质无谷蛋白饮食前后乳糜泻患者体内抗酿酒酵母抗体和抗中性粒细胞胞浆周缘抗体情况
Aliment Pharmacol Ther. 2005 Apr 1;21(7):881-7. doi: 10.1111/j.1365-2036.2005.02417.x.
2
Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.炎症性肠病中的抗中性粒细胞胞浆自身抗体和抗酿酒酵母抗体。
Turk J Gastroenterol. 2004 Dec;15(4):238-42.
3
Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.炎症性肠病中抗酿酒酵母甘露聚糖抗体:不同检测方法的比较及其与临床特征的相关性
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1143-52. doi: 10.1111/j.1365-2036.2004.02258.x.
4
Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn' s disease population.
Dig Liver Dis. 2004 Jan;36(1):29-34. doi: 10.1016/j.dld.2003.10.001.
5
Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.针对患有克罗恩病和溃疡性结肠炎的儿童及青年进行抗中性粒细胞胞浆抗体(ANCA)、抗酿酒酵母抗体(ASCA)和抗OmpC抗体的血清学检测:诊断价值及与疾病表型的相关性
Am J Gastroenterol. 2004 Nov;99(11):2235-41. doi: 10.1111/j.1572-0241.2004.40369.x.
6
Anti-Saccharomyces cerevisiae antibodies in coeliac disease.乳糜泻中的抗酿酒酵母抗体
Scand J Gastroenterol. 2007 Jul;42(7):821-6. doi: 10.1080/00365520601154996.
7
Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?炎症性肠病中的抗中性粒细胞胞浆抗体:它们是否识别一种异质性疾病的不同亚群?
Eur J Gastroenterol Hepatol. 1995 Sep;7(9):859-64.
8
[Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease].[克罗恩病患者中的抗酿酒酵母抗体]
Orv Hetil. 2001 Oct 21;142(42):2303-7.
9
Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.炎症性肠病中的免疫标志物抗酿酒酵母抗体(ASCA)和抗中性粒细胞胞浆抗体(ANCA):一种有用的诊断工具。
Minerva Gastroenterol Dietol. 2005 Jun;51(2):201-7.
10
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.抗酿酒酵母抗体和抗中性粒细胞胞浆自身抗体在炎症性肠病中的诊断价值
Am J Gastroenterol. 2001 Mar;96(3):730-4. doi: 10.1111/j.1572-0241.2001.03613.x.

引用本文的文献

1
Coeliac disease and microbiota: is it time for personalised biotics intervention? A scoping review.乳糜泻与微生物群:是时候进行个性化生物制剂干预了吗?一项范围综述。
BMJ Nutr Prev Health. 2025 Mar 22;8(1):e001100. doi: 10.1136/bmjnph-2024-001100. eCollection 2025.
2
Non-Celiac Wheat Gluten Sensitivity Model: Effects on Hepatic Morphophysiology of Wistar Rats.非乳糜泻性小麦麸质敏感模型:对Wistar大鼠肝脏形态生理学的影响
Nutrients. 2025 May 28;17(11):1842. doi: 10.3390/nu17111842.
3
The Relationship Between Gut Microbiota and Recurrent Spontaneous Abortion.
肠道微生物群与复发性自然流产之间的关系
Microorganisms. 2025 May 4;13(5):1073. doi: 10.3390/microorganisms13051073.
4
Epidemiology of Celiac Disease in Cantabria, Spain.西班牙坎塔布里亚地区乳糜泻的流行病学
Diagnostics (Basel). 2025 Feb 19;15(4):505. doi: 10.3390/diagnostics15040505.
5
Evaluation of the BIOSECURE Questionnaire in Patients Followed for Inflammatory Rheumatological and Gastrointestinal Diseases Through the Analysis of This Questionnaire.通过对生物安全问卷的分析评估该问卷在炎症性风湿性和胃肠道疾病患者中的应用情况。
J Clin Med. 2025 Jan 22;14(3):687. doi: 10.3390/jcm14030687.
6
The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative Colitis.JAK1抑制剂在溃疡性结肠炎中的细胞特异性作用。
J Clin Med. 2025 Jan 18;14(2):608. doi: 10.3390/jcm14020608.
7
Comparison of Self-Care Practices and BMI between Celiac and Non-Celiac Adolescent Populations.腹腔疾病与非腹腔疾病青少年人群自我护理行为与体重指数的比较。
Healthcare (Basel). 2024 Sep 8;12(17):1796. doi: 10.3390/healthcare12171796.
8
Expression of MicroRNAs in Adults with Celiac Disease: A Narrative Review.《乳糜泻成人中 MicroRNAs 的表达:叙述性综述》。
Int J Mol Sci. 2024 Aug 30;25(17):9412. doi: 10.3390/ijms25179412.
9
Exploration of Therapeutic Strategies of Herbal Prescriptions for Carbuncle Treatment to Suggest Modern Approaches to Inflammatory Bowel Disease: Cluster and Network Analyses of the Book «».探索治疗痈肿的中药方剂治疗策略以提出炎症性肠病的现代治疗方法:对《》一书的聚类和网络分析
Healthcare (Basel). 2024 Jul 28;12(15):1499. doi: 10.3390/healthcare12151499.
10
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease.单价XBB.1.5适配的新冠mRNA疫苗在炎症性肠病患者中的全身和黏膜免疫原性
Vaccines (Basel). 2024 Jul 15;12(7):774. doi: 10.3390/vaccines12070774.